Induction chemoimmunotherapy followed by concurrent radiotherapy in patients with locally advanced esophageal cancer: a single-arm phase 2 trial
This regimen of induction chemoimmunotherapy followed by concurrent chemoradiotherapy and maintenance immunotherapy demonstrated promising survival outcomes, a manageable safety profile, and a preserved QoL, thereby offering a viable nonsurgical alternative for patients with locally advanced ESCC.
Authors
- Xiaolin Ge (ORCID: https://orcid.org/0000-0002-9155-3641)
- H. Chen
- Zeyuan Liu (ORCID: https://orcid.org/0000-0001-6508-8590)
- Xiaojie Xia (ORCID: https://orcid.org/0009-0009-9456-1979)
- Wang Zheng
- Xinchen Sun
Institutions
- Nanjing Jiangning Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1093/oncolo/oyaf438
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00